SLC2A1 and Cognitive impairment: Our recent in vivo experiments tested with e-Cig vape (0% or 1.8% nicotine) showed reduced expression of critical genes in the mouse brain, diminished the expression of occludin and glucose transporter 1 (Glut1) proteins, and increased BBB permeability, neuroinflammation, and cognitive impairment [6].